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Abstract
Studies on human fertility genes have identified numerous risk/protective alleles involved in the occurrence of reproductive
system diseases causing infertility or subfertility. Investigations we carried out in populations at natural fertility seem to
suggest that the clinical relevance that some fertility genes are now acquiring depends on their interaction with
contemporary reproductive behaviors (birth control, delayed childbearing, and spacing birth order, among others). In recent
years, a new physiological role in human fertility regulation has emerged for the tumor- suppressor p53 gene (P53), and the
P53 Arg72Pro polymorphism has been associated with recurrent implantation failure in humans. To lend support to our
previous observations, we examined the impact of Arg72Pro polymorphism on fertility in two samples of Italian women not
selected for impaired fertility but collected from populations with different (premodern and modern) reproductive
behaviors. Among the women at near-natural fertility (n=98), the P53 genotypes were not associated with different
reproductive efficiency, whereas among those with modern reproductive behaviors (n=68), the P53 genotypes were
associated with different mean numbers of children [Pro/Pro=0.75,Pro/Arg=1.7,Arg/Arg=2, (p=0.056)] and a
significant negative relationship between the number of children and P53 Pro allele frequencies (p=0.028) was observed.
These results are consistent with those of clinical studies reporting an association between the P53 Pro allele and recurrent
implantation failure. By combining these findings with previous ones, we suggest here that some common variants of
fertility genes may have become ‘‘detrimental’’ following exposure to modern reproductive patterns and might therefore be
associated with reduced reproductive success. Set within an evolutionary framework, this change could lead to the selection
of a set of gene variants fitter to current reproductive behaviors as the shift to later child-bearing age in developed
countries.
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Introduction
Human fertility is a complex trait determined by gene-
environmental interactions in which genetic factors represent a
significant component [1,2]. Fertility is regulated by a large
number of genes acting in various different steps to establish both
male and female fertility [3,4]. Besides the numerous rare
mutations associated with infertility, many polymorphic variants
(alleles) have also been identified in fertility genes, but how these
alleles affect human fertility remains unclear [3,4].
Different alleles at a locus are usually thought to be associated
only with small fertility differences (or no differences at all) and
contribute very little to overall fitness, otherwise selection would
lead to their fixation or elimination [5,6]. This scenario would fit
well with the complex trait model proposed for fertility which
predicts the contribution of many genes, each with a small effect.
In recent investigations we were able to examine the way the
variation of some fertility-related genes may influence reproductive
efficiency in natural (or near-natural) fertility populations (i.e. in
the absence of deliberate birth control) [7,8] and could confirm the
absence of a relevant effect of gene variants on total fertility (i.e.,
fertility of subjects at the end of their reproductive lifetime). Other
recent studies on fertility candidate genes have identified risk/
protective alleles involved in the occurrence of reproductive system
diseases causing infertility or subfertility [9–12]. More recently,
some of these polymorphisms have been studied also in relation to
their role in positive outcomes after in vitro fertilization (IVF) or
other assisted reproductive technology (ART) procedures [13–15].
The emerging picture seems to indicate that fertility genes
represent a set of genes whose role is changing, and acquiring
clinical relevance, a phenomenon we hypothesize may be due to
their interaction with the present environmental context, i.e.,
modern reproductive patterns (e.g., birth control, family planning,
delayed childbearing, and spacing birth order) followed in many of
today’s industrialized countries.
Whether for economic, social, or educational reasons, young
couples have begun to postpone starting a family and reduce
family size, and women to delay having first childbirth or decide to
remain childless. In Western Europe, the mean age at which
women deliver their first child rose from 22–25 years in 1950 to
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decline. Studies on age-related female fertility indicate that it
begins to decline at age 30 years and then more rapidly after age
35. While the decline in male fertility is also age-dependent, it
becomes significant only after age 45 years [17]. Furthermore,
postponement of first childbirth is accompanied by increased
serious health risks for mothers and their children. A major effect
of this shift in reproductive behaviors is a progressive reduction of
fertility. Across Europe, total fertility rates ([TFR], average
number of children per woman) decreased dramatically from
2?6 between 1960 and 1964 to 1?5 between 2004 and 2005, a
value well below 2?1, the TFR needed for generation replacement,
i.e. the level of fertility at which a population exactly replaces itself
from one generation to the next (http://ec.europa.eu/
employment_social/social_situation/docs/sec_2007_638_en.pdf;
last accessed February 23, 2012).
To verify the hypothesis that exposure to different reproductive
behaviors may influence the action of fertility-related genes, we
examined the role of another fertility gene, P53, in two samples of
the Italian population with different reproductive patterns. The
tumor-suppressor p53 gene (P53) has a pivotal role in tumor
prevention and DNA damage response. In response to a variety of
cellular stresses, the p53 protein (p53) is able to activate target
genes to induce cell cycle arrest, apoptosis, and senescence.
Through these mechanisms, p53 promotes DNA repair or the
elimination of damaged cells, thus contributing to tumor
suppression [18].
In the last years, a new physiological role has emerged for p53
as a fertility regulator [19]. In mice maternal reproduction p53
was found to control the implantation of fertilized eggs, a function
p53 exerts by activating leukemia inhibitory factor (LIF), an
essential gene for blastocyst implantation [20]. So too in humans
LIF appears to be involved in egg implantation, given that LIF
levels are significantly decreased in women with unexplained
infertility [21]. The role of p53 in the regulation of female fertility
has been confirmed by more recent observations of how other
members of the p53 family (p63 and p73) participate in the control
of human maternal reproduction [22].
Many single nucleotide polymorphisms (SNPs) of P53 have been
identified in human populations, but the one most extensively
studied is rs1042522, located in codon 72 of exon 4, where the
change CGCRCCC results in an Arg/Pro substitution. The Pro
and Arg alleles at codon 72 are not functionally equivalent: Pro72
encodes a weaker p53 isoform than that encoded by Arg72 to
induce apoptosis and suppress transformation, while it is better at
favoring cell cycle arrest [23]. The two alleles at P53 codon 72
differ also in their transcriptional activity toward a subset of p53-
responsive genes. Notably, cells containing P53 Arg72 produce
twice as much LIF as those containing the Pro72 allele [24]. A
growing body of epidemiological data is consistent with these in
vitro studies: the P53 Pro72 allele was found at increased
frequencies among women undergoing in vitro fertilization (IVF)
and, among such women, it was associated with higher
implantation failure [24,25]. This clinical observation confirms
that p53 regulates maternal reproduction in humans as well.
So far, the P53 Arg72Pro polymorphism has been found to
influence human reproduction in a pathological context. We
examined it in two samples of women not selected for impaired
fertility and collected from populations with different reproductive
patterns. The first was collected from a rural population from
Southern Italy, which, according to population and sample fertility
rate, has reproduced with a pre-modern or near-natural
reproductive pattern. The second was collected from an urban
population from northeastern Italy whose fertility rate indicates a
pattern of reproduction typical of modern societies where birth
control is practiced.
The aim of the present study was to examine the role of P53
polymorphism in fertility at the population (not clinical) level and
the possible effects different reproductive behaviors may have on
it.
Results
The characteristics of the samples are reported in Table 1. The
observed fertility rate for the women in the Southern Italian
sample was 3.762.3 children (range, 0–11). This value was
intermediate with respect to the range of 4.8-3.1 reported for
cohorts of women born in the same geographic area and in the
same period (1900–1930) [26]. The fertility rate for the women in
the Northern Italian sample was 1.860.97 children (range, 0–4).
This value was near the lower end of the range of 2.4–1.7 reported
for cohorts of women born in the same geographic area and in the
same period (1921–1953) [27]. Spontaneous abortion rates were
calculated as the ratio between the number of abortions and the
number of children. No population data concerning cohorts of
women of the same periods are available for a comparison with the
sample data; however, the abortion rates (abortion/livebirths)
reported for the same geographic areas (Northern Italy, 0.13) and
(Southern Italy, 0.12) are available for the period 1997–2001
[http://www3.istat.it/dati/catalogo/asi2004/PDF/Cap3.pdf, last
accessed February/27/2012].
The P53 Arg72Pro polymorphism was examined in the
Southern Italian (n=152) and the Northern Italian (n=102)
samples. The observed genotype frequencies (Southern Italy: Pro/
Pro 0.112, Pro/Arg 0.382, Arg/Arg 0.507; Northern Italy: Pro/
Pro 0.069, Pro/Arg 0.363, Arg/Arg 0.568) agreed with those
expected according to the Hardy-Weinberg equilibrium. The P53
Pro allele frequencies of the two samples were 0.250 (Northern
Italy) and 0.303 (Southern Italy), similar to those reported for the
Italian population [28]. Table 2 reports the mean number of
children associated with P53 genotypes in the two samples. Among
the women in the Southern Italian sample, the P53 genotypes
were not found to be associated with a different number of
children. In contrast, among the women in the Northern Italian
sample, the P53 genotypes were associated with different numbers
of children, with a trend among the genotypes (from the lowest
number of children to the highest) Pro/Pro,Pro/Arg,Arg/Arg
(p=0.056). The power calculation of this analysis is low (1-
b,0.80) and the probability to make a type II error is high
(b.0.20). We calculated that we would need to have approxi-
mately 50 subjects in each class to reach a statistical power of 0.80.
But because of the P53 Pro allele frequency, we would have to
collect about 800 subjects to find about 50 Pro/Pro homozygotes.
Table 1. Characteristics of the two study samples.
Southern Italy Northern Italy
Age (yrs)* 82.266.0 70.369.4
Total no. of children 342 119
Mean no. of children* 3.762.3 1.860.97
Total no. of abortions 65 6
Abortion/children ratio 0.19 0.05
Childless subjects (%) 7.7 11.8
*Plus-minus value is equal to plus-minus standard deviation.
doi:10.1371/journal.pone.0035431.t001
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approach: the subjects were grouped into different classes
according to the number of children, and the P53 allele
frequencies were calculated for each class (Table 3). The chi
square test for trend of proportions showed a significant negative
relationship between the number of children and P53 Pro allele
frequencies (chi square=4.9,d.f.=1, p=0.028) only in the
Northern Italian sample, where the highest Pro allele frequencies
were found in the class with no children (0.438) and the lowest in
the class with two or more children. No significant trend was
observed among the women in the Southern Italian sample (chi
square=0.11,d.f.=1, p=0.74). In neither sample were differences
observed in the mean number of spontaneous abortions associated
with the P53 genotypes (Southern Italian sample, p=0.40;
Northern Italian sample, p=0.62) (data not reported).
Discussion
This study examined the association of the P53 Arg72Pro
polymorphism with fertility at the population level, specifically in
women not selected for fertility disorders. The data show that in
the sample of women at near-natural fertility, the P53 genotypes
are not associated with differential fertility. Conversely, in the
sample of women with modern reproductive behaviors, the P53
genotypes are associated with a different reproductive efficiency,
with the lowest fertility occurring among the Pro/Pro genotype
carriers. The observation of a reduced fertility associated with the
Pro allele was confirmed by subsequent chi square for trend of
proportions test that shows a significant inverse relationship
between Pro allele frequency and classes according to number of
children.
These results should be interpreted with caution. The size of the
samples is relatively small and, fertility being a complex trait,
numerous other genetic and environmental factors, including male
fertility, could have contributed to determine the phenotype
‘‘number of children’’ we examined. Nevertheless, the results
obtained in the sample of women with a modern reproductive
pattern are consistent with those of clinical studies reporting an
excess of P53 Pro/Pro genotypes in women with unexplained
infertility undergoing IVF and, among these, in women with
higher implantation failure [24,25]. The observation that P53
genotypes are not associated with different numbers of spontane-
ous abortions, which, by definition, represent the end of an
established pregnancy, is not unexpected, given that P53 is
involved in egg implantation instead.
It is interesting to observe how the phenotypic effects of P53
genotypes vary according to reproductive environments. In
women from the population at near-natural fertility, P53
genotypes do not influence fertility, suggesting that the possible
small reduction of fertility associated with the P53 Pro allele could
have been offset by the pre-modern reproductive behavior (little or
no birth control, lower age at first birth, etc.). In the sample from
the population where modern reproductive behaviors began to be
followed, the P53 genotype effect begins to shift toward differential
fertility. Set within the broader context of contemporary society,
the role of P53 genotypes eventually tends to acquire clinical
relevance, being associated with infertility and the successful/or
not outcome in women undergoing IVF [24,25].
These findings are similar to what we have observed for other
fertility-related genes. One gene we studied was ESR1, which
encodes estrogen receptor alpha [7]. We examined the association
of two ESR1 polymorphisms (rs 2234693, rs9340799) with fertility
in two populations at near-natural (Italian) and natural (Afro-
Ecuadorian) fertility and observed that the effects of ESR1
genotypes on fertility varied according to the reproductive
environment: in the women from the African-Ecuadorian
populations ESR1 genotypes (pp and xx) influenced the fertility
level, predisposing to have an elevated number of children (higher
than the median value). In the Italian women, the same genotypes
showed an association with a low rate of spontaneous abortions,
but without any impact on total fertility. In today’s industrialized
societies, however, the effects of the ESR1 genotype manifest as a
successful outcome in women undergoing IVF [13,14] or
predisposing to premature ovarian failure [12], or exerting a
protective effect against azoospermia or idiopathic oligospermia in
men [11]. In other words, in populations with pre-modern
reproductive patterns, the ESR1 genotypes influence at most the
number of children, whereas within the context of modern
reproductive behaviors, they seem to be associated instead with
having children or not.
Another example is the angiotensin I-converting enzyme (ACE)
gene. Recently, the ACE I/D polymorphism was found associated
with recurrent spontaneous miscarriages [29–31]. We analyzed
the relationship between the ACE I/D polymorphism and the
number of spontaneous abortions, the number of pregnancies and
completed fertility in a sample of Italian women at near-natural
fertility [8]. We were able to tease out in this population sample an
association between an ACE genotype (DD) and recurrent
miscarriages, as previously reported in case-control studies [29–
31]; however, no difference in completed fertility was observed
among the women carrying the different ACE genotypes, as those
carrying the ACE risk genotype and prone to miscarriage
overcame the problem by counterbalancing it with a greater
number of pregnancies. In contrast, published data on contem-
porary women appear to indicate that the ACE genotype could
Table 2. Mean number of children (6SD) according to P53
genotype. The number of subjects is given in brackets.
P53 genotype Southern Italy Northern Italy
Pro/Pro 3.662.2(11) 0.7561.0 (4)
Pro/Arg 3.662.1 (30) 1.6760.9 (21)
Arg/Arg 3.762.6 (50) 1.9561.0 (38)
p 0.98 0.056
doi:10.1371/journal.pone.0035431.t002
Table 3. P53 allele frequencies in subjects grouped according
to number of children.
No. of
children Northern Italy Southern Italy
No. of subjects Pro freq.
No. of
subjects Pro freq.
0 8 0.438 7 0.214
1 13 0.231 13 0.231
2 29 0.224 9 0.389
3 11 0.136 17 0.324
4 2 0.0 12 0.250
.4 0 0.0 33 0.287
p 0.027 0.74
doi:10.1371/journal.pone.0035431.t003
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because of their shorter reproductive lifespan due to postponement
of childbearing. Similarly, other fertility related genes which do
not seem to have any effects on fertility in populations with pre-
modern reproductive patterns have been recently associated with
infertility or ovarian stimulation outcome [32–33] (Table 4).
The emerging picture of the interactions between fertility genes
and contemporary reproductive behaviors suggests that fertility
genes may represent a further example of genes ‘‘rendered
detrimental by progress’’. The hypothesis for a ‘‘genotype
rendered detrimental by progress’’ was first advanced by J.V.
Neel [34] in 1962 in an attempt to explain the emergence of
diabetes epidemics in the United States and other technologically
advanced societies. He speculated the existence of a ‘‘thrifty
genotype’’, i.e., a set of genes shaped for our hunter-gatherer
ancestors to survive on an intermittent and unpredictable food
supply and with elevated physical activity. Such a genotype would
be exceptionally efficient in the utilization of food and allow the
storage of fat reserves in times of plenty for later times of shortage.
Once highly advantageous for ensuring survival, these thrifty genes
have become detrimental in modern societies where food is
plentiful or overabundant and overall physical activity has
declined. Moreover, they may be identified with susceptibility
genes for complex diseases like type 2 diabetes or obesity. The
notion that an ‘‘ancient’’ genotype could increase disease
susceptibility has been put forth to account for the growing
prevalence of such complex disorders as hypertension, coronary
heart disease and Alzheimer’s disease. Some 30 years later, in
1998 Neel suggested broadening the original concept to include
the ‘‘civilization syndromes’’ or the ‘‘altered lifestyle syndromes’’
for diseases which can be explained by a similar evolutionary
framework [35]. This hypothesis, originally based on disease
physiology and epidemiology, found recent support from popula-
tion genetic studies showing that, for several susceptibility
polymorphisms for common disease, the risk allele is the ancestral
allele, the result of an ancient adaptation no longer advantageous
in the modern environment [36].
Taken together, our data seem to indicate that fertility genes
might easily fit within the ‘‘altered lifestyle syndromes’’ hypothesis,
and, at least for the P53 and ACE genes, in the ancestral
susceptibility model as well, given that both the Pro allele of P53
and the D allele of ACE are the ancestral alleles [36,37]. There is,
however, an important difference between fertility genes and other
genes ‘‘rendered detrimental by progress’’: the latter are mostly
susceptibility genes for diseases occurring in post-reproductive age
(coronary heart disease, hypertension, Alzheimer’s disease, among
others) and therefore escape selection, while the natural fertility
gene variants may be associated with differential fitness and,
hence, be under selective pressure. This process could promote the
selection of a set of gene variants fitter to the current reproductive
patterns, thus favoring, for example, reproduction at a later age as
well.
On the whole, the picture we have outlined suggests the
occurrence of complex interactions between genetic factors and
reproductive environments and that fertility genes are a further set




The Southern Italian population sample included 152 appar-
ently healthy unrelated women in the post-reproductive age
collected for a population survey of the elderly population of
Cilento, a rural area in the district of Salerno, Southern Italy. All
subjects were born before 1930 (1900–1930) and lived in a society
where the demographic transition (increase in life expectancy and
declining fertility) had just started [38]. In Italian women born in
the same geographic area and in the same year range, the mean
age at marriage was 22.4 years [26], and the fertility rate was well
over the replacement level (range, 4.8-3.1). All subjects were
recruited consecutively without selection criteria, except age (.70
years) and birthplace. Fertility data (number of children) were
ascertained by interviews and were collected for only 98 women.
Written informed consent was obtained from all subjects. The
protocol for the collection of biological material for the scientific
studies was approved by the institutional committees (Local Health
Unit ASL SA 3).
The Northern Italian population sample comprised 102 healthy
unrelated women recruited as a control sample during an
epidemiological study on Alzheimer’s disease (AD) carried out at
the Verona Hospital. All subjects were born between 1921/1953
in the urban area of Verona, northeastern Italy, and lived in a
society where the demographic transition was already under way.
In the Italian women born in the same geographic area in the
same year range, the mean age at marriage was 25.2 years and the
fertility rate was near/below the replacement level (range, 2.4-1.7)
[27]. All subjects were recruited consecutively without selection
criteria, except age that matched that of AD patients (.60 years)
and birthplace (Verona province). Fertility data (number of
children) were ascertained by interviews and were collected for
only 63 women. Written informed consent was obtained from all
subjects. The protocol for the collection of biological material for
the scientific studies was approved by the institutional ethics
committee (Hospital of Verona, Ethical Committee protocol
no. 1268/131/2006). The study was approved by the Department
Board (12/06/2009 session) of the former ‘‘Department of
Genetics and Molecular Biology’’ of La Sapienza University,
Rome.
Laboratory Methods
Venous blood was drawn in ethylenediaminetetraacetic acid
(EDTA) from all subjects after overnight fasting. High-molecular-
weight DNA was extracted from whole blood according to the
procedure described by Miller et al. [39]. The P53 SNP
(rs1042522) was investigated by an allele-specific PCR according
to Giannoudis et al. [40]. In brief, P53 Arg and Pro sequences
were amplified in a single reaction with an allele-specific primer
pair: P53 Arg sequences were detected using the primer pair p531,
58-GTCCCCCTTGCCGTCCCA-38, and Arg–, 58-
Table 4. Fertility related polymorphic genes which have been
investigated for their role in populations with different
reproductive patterns.
Gene Phenotypes Ref
Premodern pattern Modern pattern
ESR1 fertility level IVF outcome; POF
a 7, 12–15




P53 none infertility; IVF outcome Present invest.,24,
25
ACE none (see text) recurrent miscarriages. 8, 29–31
aPOF:premature ovarian failure; COH: controlled ovarian hyperstimulation.
doi:10.1371/journal.pone.0035431.t004
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ment; P53 Pro sequences were detected using the primer pair
Pro1, 58-GCCAGAGGCTGCTCCCCC-38 and p53–,8-
GGAAGCCAGCCCCTCAGG-38, amplifying a 206-bp frag-
ment. Visualization of the PCR product on agarose gel revealed
three different genotypic patterns.
Statistical Analysis
Allelic frequencies were determined by the gene-counting
method. The agreement of the genotype distribution with
Hardy–Weinberg expectations was verified with the chi square
test. Comparisons between the mean number of children
associated with different P53 genotypes were performed using
analysis of variance (ANOVA). Estimates of statistical power (1-b)
were calculated according to Cohen [41] i.e. we calculated the
probability of rejecting the null hypothesis, when the null is false.
In this analysis the null hypothesis is that the P53 genotypes are
associated with the same number of children. The Cochran-
Armitage chi square test for trend of proportions [42] was used to
verify the presence of a linear trend between the number of
children and P53 allele frequencies.
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